baber/WOPTO huggingface dataset:
Patent AU-2018359018-B2 (AU)
Title: Peptide antibiotics
Inventor: COOPER MATTHEW
IPC: A61K38/00
Filed: 2018-11-02
Granted: 2022-11-24
Abstract: There is provided a range of novel compounds. These novel compounds may demonstrate a broad spectrum antibacterial and antifungal activity. These compounds may be active against the emerging polymyxin resistant bacteria. These compounds may also be useful when used in conjunction with other pharmaceutically active agents.
Patent AU-2018395933-B2 (AU)
Title: Content management client synchronization service
Inventor: GOLDBERG ISAAC
IPC: G06F16/178
Filed: 2018-12-17
Granted: 2021-04-01
Abstract: The disclosed technology relates to a system configured to identify at least one difference between a sync tree and at least one of a remote tree and a local tree. The sync tree represents a known synced state between a server state and a file system state, the remote tree represents the server state, and the local tree represents the file system state. The system may further generate, based on the at least one difference, a set of operations configured to converge the server state and the file system state and manage the execution of the set of operations.
Patent AU-2018434685-B2 (AU)
Title: Meter electronics and methods for verification diagnostics for a flow meter
Inventor: DOWNING BERT J
IPC: G01F15/02
Filed: 2018-07-30
Granted: 2022-01-06
Abstract: A method for verifying accurate operation for a flow meter (5) is provided. The method entails receiving a vibrational response from the flow meter (5), wherein the vibrational response comprises a response to a vibration of the flow meter (5) at a substantially resonant frequency. At least one gain decay variable is measured. It is then determined whether the gain decay variable is outside a predetermined range. A filter used in a stiffness calculation is adjusted if the gain decay variable is outside the predetermined range.
Patent AU-2019203452-B2 (AU)
Title: System for stimulating bone growth, tissue healing and/or pain control, and method of use
Inventor: LEUTHARDT ERIC
IPC: A61N1/05
Filed: 2019-05-16
Granted: 2020-03-05
Abstract: A system for use in stimulating bone growth, tissue healing, and/or pain control is described. The system includes a screw, a battery, a controller, and means for connecting the battery such that current is routed from the battery through the screw and thence to a target area of interest requiring treatment. The screw includes an elongate shaft having a length extending 5 between opposite ends. The shaft has an insulating coating extending along at least a portion of the length. The thickness of the insulating coating at various portions of the shaft is modulated to optimally direct current to a target area of interest requiring treatment. The controller adjusts the duty cycle of the current flow over the treatment period.
Patent AU-2019246785-B2 (AU)
Title: Chimeric antigen receptor and methods of use thereof
Inventor: WU CHIA-YUNG
IPC: C12N15/11
Filed: 2019-10-08
Granted: 2021-04-08
Abstract: OF THE DISCLOSURE 
The present disclosure provides a heterodimeric, conditionally active chimeric 
antigen receptor (CAR), and a nucleic acid comprising a nucleotide sequence encoding the 
CAR. The present disclosure provides cells genetically modified to produce the CAR. A 
CAR of the present disclosure can be used in various methods, which are also provided.
Patent AU-2019267088-B2 (AU)
Title: Devices and methods for in situ soil analysis
Inventor: GRABBERT NIELS
IPC: G01N33/24
Filed: 2019-05-08
Granted: 2021-08-19
Abstract: The invention relates to the field of soil analysis, in particular the technical analysis of agricultural or horticultural soils. In particular, the invention relates to a sensor device for in situ soil analysis, to a method for in situ soil analysis, and to a device set up for carrying out the soil analysis method, wherein said device, together and in interaction with one or more of said sensor devices, represents a system for in situ soil analysis. The sensor device has a sensor assembly comprising one or more sensors which are configured individually or cumulatively for the simultaneous in situ measurement of at least two of the following soil properties of a soil to be analyzed and for providing corresponding respective measurement data: (a) impedance spectrum, (b) temperature, (c) absorption spectrum NIR-VIS-UV in a spectral range from NIR (near infrared spectral range) to UV (ultraviolet spectral range), and (d) acidic or basic character, in particular pH value. In this case, the distance between in each case two of the sensors of the sensor assembly, which is defined with respect to the respective measurement variable sensors, does not exceed a value of 10 cm.
Patent AU-2019273834-B2 (AU)
Title: Automatic drug delivery device
Inventor: APPY JACQUES
IPC: A61M5/24
Filed: 2019-05-23
Granted: 2022-03-03
Abstract: The invention relates to an automatic drug delivery device (10), in particular automatic drug delivery device, for dispensing a fluid product, in particular a fluid medicament, including: a longitudinal housing (104) extending along a longitudinal axis and having a proximal end close to the dispensing site, a distal end opposite to the proximal end and a hollow interior; a removable cap (50) mountable to the proximal end of the housing (104); a syringe assembly (200) arranged a mounting position inside the housing (104) and having a hollow syringe body (204) and an injection needle (206) coupled to the hollow syringe body (204) including the fluid product; a drive mechanism (300) which can be triggered by a trigger element in order to initiate the dispensing of the fluid product; wherein the loaded drive mechanism is operatively coupled with a safety shield (102) movable within the longitudinal housing (104), wherein the safety shield (102) is biased into a proximal position in which it protrudes out of the proximal end of the longitudinal housing (104) in order to cover a needle tip (348) of the injection needle (206), and wherein the safety shield (104) is movable into a distal position in which the injection needle (206) is exposed for injection; wherein the syringe assembly is provided with a needle shield fixed to a proximal end of the hollow syringe body and covering the needle together with its sharpened needle tip; wherein the removable cap includes a flexible gripping element for engaging the needle shield on its outer circumferential surface such that removal of the removable cap results in removal of the needle shield, the flexible gripping element having a greater diameter than a proximal end of the safety shield.
Patent AU-2019355673-B2 (AU)
Title: Refrigerator
Inventor: LEE DONGHOON
IPC: F25D25/02
Filed: 2019-10-01
Granted: 2023-04-20
Abstract: A refrigerator of the present invention may comprise: a first tray assembly forming a part of an ice making cell; and a second tray assembly forming the other part of the ice making cell. The first tray assembly includes a first tray, and the second tray assembly includes a second tray. The second tray includes a first portion forming at least a portion of the ice making cell, and a second portion extending from a predetermined point of the first portion. The second portion includes a first extension part extending from a first point of the first portion and a second extension part extending from a second point of the first portion, wherein the length of the second extension part in the horizontal direction is formed longer than the length of the first extension part.
Patent AU-2020202367-B2 (AU)
Title: Providing priming cues to a user of an electronic device
Inventor: MOUSSETTE CAMILLE
IPC: A61B5/16
Filed: 2020-04-03
Granted: 2022-04-07
Abstract: An electronic device can output a priming cue prior to outputting an alert on the 
electronic device. A priming cue can be a haptic priming cue, a visual priming cue, an 
audio priming cue, or various combinations of these priming cues. The priming cue can be 
perceived by a user either consciously or subconsciously and can increase a user's 
perceptual state for the alert.
Patent AU-2020214490-B2 (AU)
Title: Information Transmission Method, Information Detection Method, Terminal Device, and Network Device
Inventor: MO YITAO
IPC: H04W72/12
Filed: 2020-01-22
Granted: 2022-11-24
Abstract: Provided are an information sending method, an information detection method, a terminal device and a network device. The information sending method comprises: sending DCI to a terminal device according to the type of current random access, wherein the DCI is used for scheduling a random access response message corresponding to the type of the current random access.
Patent AU-2020228333-B2 (AU)
Title: Augmented reality mobile edge computing
Inventor: PEAKE BENJAMIN
IPC: A63F13/358
Filed: 2020-02-25
Granted: 2023-05-25
Abstract: Processing of actions within a shared augmented reality experience is split between an edge node of a communications network (e.g., a cell tower) and a server. As a result, computation of the current state may be sharded naturally based on real-world location, with state updates generally provided by the edge node and the server providing conflict resolution based on a master state (e.g., where actions connected to different edge nodes potentially interfere with each other). In this way, latency may be reduced as game actions are communicated between clients connected to the same edge node using a peer-to-peer (P2P) protocol without routing the actions via the game server.
Patent AU-2020270557-B2 (AU)
Title: Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
Inventor: LANG FRANTISEK
IPC: A61B18/12
Filed: 2020-04-09
Granted: 2021-09-09
Abstract: A device for providing a magnetic treatment by evoking muscle contraction by a time-varying magnetic field and providing a RF treatment by heating biological structure. The device includes an applicator having an RF electrode and a magnetic field generating device. The device may also include a main unit, a human machine interface, and a control unit. The control unit adjusts a signal provided to the RF electrode and creates an RF circuit, and also adjusts the signal provided to the magnetic field generating device and creates a magnetic circuit electrically insulated from the RF circuit. The RF circuit may include a power source and a power amplifier, and the magnetic circuit may include an energy storage to supply the magnetic field generating device with electric current.
Patent AU-2020290407-B2 (AU)
Title: Mobile device case and method of detecting gun sounds using a mobile device case
Inventor: D'AMICO JOSEPH N
IPC: H04W4/00
Filed: 2020-06-08
Granted: 2022-12-08
Abstract: A mobile device case according to the present disclosure in conjunction with a processor of a mobile device is provided. The mobile device case has one or more sound sensors capable of detecting threat associated sounds such as gunshot sounds. The mobile device case transmits a sound data related to the gunshot sounds and the processor of the mobile device analyzes the sound data to obtain a location of the gun shooting. The mobile device can further notify other networked subscriber devices via a network system. The system may include a server connected to a network such that the server collects various threat events reported through mobile devices and manages threats at the target locations and at threat locations. Networked subscriber devices are used to alert respective users when the respective target locations coincide with a given threat location. The server notifies the users of respective solutions to threats.
Patent AU-2021200129-B2 (AU)
Title: Methods of treating conditions related to the S1P1 receptor
Inventor: KAM MARIA MATILDE SANCHEZ
IPC: A61P37/00
Filed: 2021-01-11
Granted: 2022-12-08
Abstract: Provided are methods of treatment of a sphingosine 1-phosphate subtype 1 (SP1 ) receptor
associated disorder comprising prescribing and/or administering to an individual in need thereof a 
standard dose of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4
tetrahydrocyclopenta[b]indol-3-yl)acetic acid (Compound 1), or a pharmaceutically acceptable salt, 
hydrate, or solvate thereof, in an amount equivalent to about 1.5 to about 2.5 mg of Compound 1, for 
example, a disease or disorder mediated by lymphocytes, an autoimmune disease or disorder, an 
inflammatory disease or disorder, ankylosing spondylitis, biliary cirrhosis, cancer, psoriasis, psoriatic 
arthritis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus 
erythematosus, inflammatory bowel disease, ulcerative colitis, type I diabetes, hypertensive 
nephropathy, glomerulosclerosis, myocardial ischemia-reperfusion injury, and acne.
Patent AU-2021201569-B2 (AU)
Title: System for generating an output file
Inventor: CARMINE JOHN SILANO
IPC: G06F3/048
Filed: 2021-03-11
Granted: 2023-01-12
Abstract: A system for creating an output comprises a processing unit, a user input module 
operably connected to the processing unit, and a video monitor operably connected to the 
processing unit. The processing unit provides on the video monitor: a grid image comprising 
multiple cells, each cell representing a duration of time; and a selection area comprising 
multiple select icons, each select icon representing a source data file. The processing unit is 
configured such that a user can create a grid layout representing the correlation between 
individual selected source data files and one or more of the multiple cells. The processing 
unit produces the output based on the correlation.  
34
Patent AU-2021203262-B2 (AU)
Title: System of delivering and storing proppant for use at a well site and container for such proppant
Inventor: OREN JOHN
IPC: B65G57/14
Filed: 2021-05-20
Granted: 2023-02-23
Abstract: The invention relates to a system structurally strengthened for proppant storage. The system 
includes a proppant container having an interior volume and having structural members to 
enhance the structural integrity to a plurality of walls when large volumes of proppant are 
positioned within the interior volume and a flow gate positioned to have a closed position to 
retain proppant in the proppant container and an opened position to release proppant from the 
proppant container by gravity feed, and a loader/unloader configured to engage the proppant 
container.
Patent AU-2021218204-B2 (AU)
Title: Methods for fungi inhibition on live plants using caboxylic acids and their salts
Inventor: RIJNEVELDSHOEK PETER
IPC: A01N37/10
Filed: 2021-08-20
Granted: 2022-12-08
Abstract: The present application relates to methods for inhibiting growth of a fungus on a 
live flowering plant (preferably turfgrass, tulip, or banana) comprising contacting 
the live flowering plant with an effective amount of a composition comprising a 
5 carboxylic acid of Formula (I) or salt thereof, wherein R is H, Ph, Ar, or a C1-C60 
alkyl (preferably calcium propionate). The present invention also relates to live 
plants products contacted with compositions comprising a carboxylic acid of 
Formula (I) or salt thereof.  
0 
R OH(J) 
10
Patent AU-2021221560-B2 (AU)
Title: Use of glutamate modulating agents with immunotherapies to treat cancer
Inventor: CORIC VLADIMIR
IPC: C07D277/82
Filed: 2021-08-25
Granted: 2023-10-26
Abstract: OF THE DISCLOSURE 
Disclosed are methods of treating cancer using a combination of an immunotherapeutic agent, 
such as, for example, a PD-1, PD-Li or CTLA-4 checkpoint inhibitor, and a glutamate modulating agent 
such as riluzole or trigriluzole. Pharmaceutical compositions and kits including the immunotherapeutic 
agents and glutamate modulating agents are also disclosed.
Patent AU-2021242202-B2 (AU)
Title: Methods for crystallization of drugs
Inventor: ZENG HONGXIA
IPC: C07D498/18
Filed: 2021-03-12
Granted: 2024-01-11
Abstract: Methods are disclosed including methods for crystallizing a material such as a drug. An example method may include combining a nucleation initiator, a surfactant solution, and an amorphous form of a drug to form a drug precursor dispersion/suspension. The method may also include incubating the drug precursor dispersion/suspension to allow the drug to convert from the amorphous form to a crystalline form.
Patent JP-3647343-B2 (JP)
IPC: F25D29/00
Filed: 2000-01-13
Granted: 2005-05-11
Abstract: PROBLEM TO BE SOLVED: To eliminate some disadvantages that a segment near a deep central location in a refrigerator chamber having an air circulation duct installed therein is hardly cooled due to a non-smooth circulation of cold air cooled by the cooler, only a location near a cold air discharging port of the cold air discharging duct has a tendency to be well cooled and there occurs a certain poor state in a uniform cooling capability in the refrigerator. SOLUTION: This refrigerator is characterized in that the same is comprised of a storing chamber 11 for storing some items to be stored; coolers 21, 25 for generating cold air flowed into the storing chamber 11; cold air passages 23, 27, 28 and 30 for guiding the cold air into the storing chamber 11; a member 42 for use in discharging cold heat generated by the cold air flowing in the cold air passages 23, 27, 28 and 30; and a temperature sensing means 75 installed around the member 42.
Patent JP-3613329-B2 (JP)
IPC: F16J3/02
Filed: 2000-07-18
Granted: 2005-01-26
Abstract: The pump comprises a push button (5), movable relative to a support (4), having a central conduit (32) into which the product penetrates through an opening before being distributed. The support defines with the push button, around the central conduit, a variable volume pumping chamber (34). The pump also comprises a membrane (50) having a central part (51) into which the central conduit is inserted. The membrane is arranged so as to isolate the pumping chamber from the central conduit openings (36) when the pumping chamber volume increases and the product is sucked into it. An Independent claim is also included for the recipient equipped with pump.
Patent JP-4481491-B2 (JP)
IPC: C12Q1/689
Filed: 1999-04-01
Granted: 2010-06-16
Abstract: The present invention provides a method of detecting a target nucleotide sequence in a nucleic acid molecule, which comprises: (a) binding of an oligonucleotide probe to said nucleic acid molecule; (b) selective labelling of the bound oligonucleotide probe in the presence of said target nucleotide sequence; (c) hybridization of the labelled oligonucleotide to a complementary sequence; and (d) subsequent detection of the label. Such methods are suitable for qualitative and quantitative assays of microbiological populations.
Patent JP-4446603-B2 (JP)
IPC: C12Q1/6897
Filed: 1999-05-20
Granted: 2010-04-07
Abstract: There is provided a non-human animal comprising a genetic construct, the genetic construct comprising: (i) a nucleotide sequence forming a transcriptional enhancer of human cytochrome P450 CYP3A4 production or expression, and (ii) a gene encoding a reporter molecule, wherein the nucleotide sequence includes each of the following nuclear response elements from the 5' flanking region of CYP3A4: SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5.
Patent JP-4395260-B2 (JP)
IPC: F02B23/00
Filed: 1999-09-13
Granted: 2010-01-06
Abstract: An engine modification particularly suitable for permitting an engine, which initially ran on diesel fuel (diesel cycle) to run on gasoline (Otto cycle), includes a spacer plate connected between a cylinder head and the engine block for lowering the compression ratio of the engine. The inlet gas flow is modified so that the combustion charge introduced into the cylinder through at least one inlet valve is caused to move around the combustion chamber so that, during the period of the spark, much of the charge passes close to the spark plug to thereby obtain efficient burning of the combustion charge. A spacer plate for causing the required movement of the gas being introduced is also disclosed.
Patent JP-4290893-B2 (JP)
IPC: H01L31/0203
Filed: 2000-01-06
Granted: 2009-07-08
Abstract: A package for optical components and a method for making the package are disclosed. The package comprises a quasi-planar substrate having a positioning floor, a platform and an optional ring frame of precisely determined height. Optical components picked and placed on a substrate floor, a raised platform and frame. A flexure assembly allows fine positioning of components requiring critical optical alignment.
Patent JP-4728486-B2 (JP)
IPC: B23B27/14
Filed: 2000-02-24
Granted: 2011-07-20
Abstract: The present invention comprises a method for coating at least one substrate with a carbonitride-containing coating by a MT CVD process which includes heating a substrate or substrates to a reaction temperature in a reaction chamber and then introducing into the reaction chamber a deposition process gas comprising from about 1 to about 30% of a hydrogen halide and predetermined amounts of a carbon/nitrogen source, a metal-halogen compound, H2, and optionally N2 so that a layer of the carbonitride-containing coating deposits on the surface of the substrates or substrates. The present invention also includes embodiments for coating at least one substrate with a carbonitride-containing coating by a MT CVD process which includes maintaining a temperature gradient in the reaction chamber during the introduction of the deposition process gas into the reaction chamber. Carbonitride-containing coatings that may be applied by the method include carbonitrides, oxycarbonitrides, and borocarbonitrides of Ti, Hf, Zr, V, Nb, and Ta and their mixtures and alloys.
Patent JP-4926320-B2 (JP)
IPC: A61K39/395
Filed: 2000-04-28
Granted: 2012-05-09
Abstract: Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate and prodrug compositions and methods using the new VEGF-specific antibodies are also provided. <IMAGE>
Patent JP-4531277-B2 (JP)
IPC: H04L47/724
Filed: 2001-03-01
Granted: 2010-08-25
Abstract: A service setting system, a network service providing method and a communication service, in which in making a communication via a network, a service condition of a network resource contained in individual communication device is set up so that the network service corresponding to the whole communication path intended for the communication meets a predetermined request is disclosed.
Patent JP-3612704-B2 (JP)
IPC: C09D11/322
Filed: 2001-04-05
Granted: 2005-01-19
Abstract: Disclosed is an ink jet recording ink set having light color inks of a plurality of colors and dark color inks of a plurality of colors. Each of the light color inks has at least a pigment, a solvent and a fine polymer particle and each of the dark color inks having at least a pigment and a solvent. Furthermore, each of the dark color inks either do not contain a fine polymer particle or contain a fine polymer particle in smaller quantity than the light color inks.
Patent JP-4742191-B2 (JP)
IPC: A61K38/00
Filed: 2001-06-14
Granted: 2011-08-10
Abstract: Producing (M1) an active glycoprotein with an acidic sugar-chain containing a mannose-6-phosphate at its non-reducing terminal comprises using a yeast, is new. Independent claims are also included for: (1) the glycoproteins produced by (M1), having an acidic sugar-chain containing mannose-6-phosphate at its non-reducing terminal; (2) drug compositions for treating and/or preventing lysosomal diseases containing the glycoproteins; and (3) producing active glycoproteins of formula (I)-(VII) having a high-mannose-type sugar-chain that contains a mannose-6-phosphate at its non-reducing terminal by using yeast. [Image] where P : P(O)(OH)O 2->. ACTIVITY : Nephrotropic; Hemostatic. No biological data given. MECHANISM OF ACTION : None given in source material.